Two Indian Healthcare Companies Jointly Steps in M&A Deals
US-based generic drug maker Mylan Inc is going to pay USD 1.6 billion plus potential additional consideration of up to […]
Say something
Tags: bangalore, Business/Finance, CEO, Clinical Research, food and drug administration, Generic drug, Health/Medical/Pharmaceuticals, injectable products, M&A, marketable injectable products, mumbai, Mylan, Mylan Inc., pharmaceutical, Pharmaceutical sciences, Pharmacology, Second Stock Issuance, Strides Arcolab, Strides Arcolab Ltd, USD
Strides Acrolab Gets FDA Approval for Generic Cancer Drug
Indian drug firm Strides Arcolab has received USFDA approval for the generic Fluorouracil Injection which will be used to treat […]
-
-
Flipkart Health+ App Launched
06-04-2022
